Cite Filings / SYRE / 0000932471-25-001050

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Spyre Therapeutics, Inc. Filed 2025-07-29 Acc 0000932471-25-001050

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-04-22 SCHEDULE 13G Statement of Beneficial Ownership
2025-08-05 S-8 Securities Offered to Employees in Benefit Plans
2025-08-05 8-K Results of operations
2025-08-05 10-Q Quarterly Report
2025-07-29 SCHEDULE 13G Statement of Beneficial Ownership
2025-05-01 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…